Considerations for Pooled Testing of Employees for SARS-CoV-2.
Journal
Journal of occupational and environmental medicine
ISSN: 1536-5948
Titre abrégé: J Occup Environ Med
Pays: United States
ID NLM: 9504688
Informations de publication
Date de publication:
01 01 2021
01 01 2021
Historique:
entrez:
30
12
2020
pubmed:
31
12
2020
medline:
22
1
2021
Statut:
ppublish
Résumé
To identify important background information on pooled tested of employees that employers workers, and health authorities should consider. This paper is a commentary based on the review by the authors of pertinent literature generally from preprints in medrixiv.org prior to August 2020. Pooled testing may be particularly useful to employers in communities with low prevalence of COVID-19. It can be used to reduce the number of tests and associated financial costs. For effective and efficient pooled testing employers should consider it as part of a broader, more comprehensive workplace COVID-19 prevention and control program. Pooled testing of asymptomatic employees can prevent transmission of SARS-CoV-2 and help assure employers and customers that employees are not infectious.
Identifiants
pubmed: 33378322
doi: 10.1097/JOM.0000000000002049
pii: 00043764-202101000-00001
pmc: PMC7773162
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1-9Subventions
Organisme : NIGMS NIH HHS
ID : U54 GM104942
Pays : United States
Informations de copyright
Copyright © 2020 American College of Occupational and Environmental Medicine.
Déclaration de conflit d'intérêts
Schulte, Weissman, Luckhaupt, de Perio, Beezhold, Piacentino, Radonovich, Hearl, and Howard have no relationships/conditions/circumstances that present potential conflict of interest.
Références
Centers for Disease Control and Prevention. Interim guidance for use of pooling procedures in SARS-CoV-2 diagnostics, screening, and surveillance testing; 2020a. Available at: https://www.cdc.gov/coronavirus/2019-ncov/lab/pooling-procedures.html. Accessed September 29, 2020.
Centers for Disease Control and Prevention. Interim guidance for Business and Employers Responding to Coronavirus Disease 2019 (COVID-19) May 2020; 2020b. Available at: https://www.cdc.gov/coronavirus/2019_ncov/community/guidance-businessresponse.html. Accessed September 29, 2020.
Abdalhamid B, Bilder CR, McCutchen EL, Hinrichs SH, Koepsell SA, Iwen PC. Assessment of specimen pooling to conserve SARS CoV-2 testing resources. Am J Clin Pathol 2020; 153:715–718.
Lohse S, Pfuhl T, Berko-Göttel, et al. Pooling of samples for testing for SARS-CoV-2 in asymptomatic people. Lancet Inf Dis 2020; 20:1231–1232.
Abid S, Ferjani S, El Maissi A, et al. Assessment of samples pooling for SARS-CoV-2 molecular testing for screening of asymptomatic persons in Tunisia. Diagn Microbiol Infect Dis 2020; 98:115125.
Bilder CR, Tebbs JM. Pooled-testing procedures for screening high volume clinical specimens in heterogeneous populations. Stat Med 2012; 31:3261–3268.
Pilcher CD, Westriech D, Hudgens MG. Group testing for SARS-CoV-2 to enable rapid scale-up of testing and real-time surveillance of incidence. J Inf Dis, jiaa 2020; 222:378.
Verwilt J, Mestdagh P, Vandesompele J. 2020. Evaluation of efficiency and sensitivity of ID and 2N sample pooling strategies for diagnostic screening purposes. Available at: https://www.medrxiv.org/content/10.1101/2020.07.17.20152702v1.full.pdf. Accessed September 29, 2020.
Edouard S, Prudent E, Gautret P, Memish Z, Raoult D. Cost-effective pooling of DNA from nasopharyngeal swab samples for large-scale detection of bacteria by real-time PCR. J Clin Microbiol 2015; 53:1002–1004.
Nguyen NT, Aprahamian H, Bish EK, Bish DP. A methodology for deriving the sensitivity of pooled testing based on viral load progression and pooling dilution. J Trans Med 2019; 17:252.
Bilder C, Tebbs J, Chen P. Informative retesting. JASA 2010; 105:942–955.
Dorfman R. The detection of defective members of large populations. Ann Math Stat 1943; 14:436–440.
Litvak E, Tu XM, Pagano M. Screening for the presence of a disease by pooling sera samples. J Am Stat Assoc 1994; 89:424–434.
Hourfar M, Themann A, Eickmann M, et al. Blood screening for influenza. Emerg Inf Dis 2007; 13:1081–1083.
White D, Kramer L, Backenson P, et al. Mosquito surveillance and polymerase chain reaction detection of West Nile Virus New York State. Emerg Inf Dis 2001; 7:643–649.
McMahan CS, Tebbs JM, Bilder CR. Two-dimensional informative array testing. Biometrics 2012; 68:793–804.
Kim H-Y, Hudgens MG, Dreyfuss JM, Westreich DJ, Pilcher CD. Comparison of group testing algorithms for case identification in the presence of test error. Biometrics 2007; 63:1152–1163.
Hogan CA, Sahoo MK, Pinsky BA. Sample pooling as a strategy to detect community transmission of SARS-CoV-2. JAMA 2020; 323:1967–1969.
Ben-Ami R, Klochendler A, Seidel M, et al. Hebrew University-Hadassah COVID-19 diagnosis team. Large-scale implementation of pooled RNA extraction and RT-PCR for SARS-CoV-2 detection. Clin Microbiol Infect 2020; 26:1248–1253.
Cleary B, Hay JA, Blumenstiel B, Gabriel S, Regev A, Mina MJ. Efficient prevalence estimation and infected sample identification with group testing for SARS-CoV-2. medRxiv: Preprint 2020.
Mutesa L, Ndishimye P, Butera Y, et al. A strategy for finding people infected with SARS-CoV-2: optimizing pooled testing at low prevalence. medRxiv: Preprint 2020.
Cabrera JJ, Rey S, Perez S, et al. Pooling for Sars-Cov-2 control in care institutions. medRxiv: Preprint, 2020, June 02. BMC Infect Dis 2020; 20:745https://doi.org/10.1186/5/2879-020-0544b-0
doi: 10.1186/5/2879-020-0544b-0
Theagarajan LN. Group testing for COVID-19: how to stop worrying and test more. arXiv 2020; https://arxiv.org/pdf/2004.06306.pdf
Sinnott-Armstrong N, Klein D, Hickey B. Evaluation of group testing for SARS-CoV-2 RNA. medRxiv: Preprint 2020.
Yelin I, Aharony N, Shaer Tamar E, et al. Evaluation of COVID-19 RT-qPCR test in multi-sample pools. Clin Infect Dis 2020; [Epub ahead of print].
Ghosh S, Rajwade A, Krishna S, et al. Tapestry: a single-round smart pooling technique for COVID-19 testing. medRxiv: Preprint 2020.
Crozier A, Mckee M, Rajan S. Fixing England's COVID-19 response: learning from international experience. J Royal Soc Med 2020; 1–6. doi 10.1177/0141076820965533.
Wu T, Ge Y, Zhao K, et al. A reverse-transcription recombinase-aided amplification assay for the rapid detection of N gene of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Virology 2020; 549:1–4.
Suo T, Liu X, Fing J, Guo M, et al. ddPCR. Use more accurate tool for SARS-CoV-2 defection in low viral load specimens. Emerging Microbes and Infections 2020; 9:1259–1268.
Schmid-Burgk JL, Schmithausen RM, Li D, et al. LAMP-Seq: population-scale COVID-19 diagnostics using combinatorial barcoding. biorxiv 2020; https://www.biorxiv.org/content/10.1101/2020.04.06.025635v2
Mulu A, Alemayehu DH, Alemu F, et al. Evaluation of sample pooling for screening SARS-CoV-2. medRXiv 2020; Accessed September 29, 2020.
Augenblick N, Kolstad JT, Obermeyer Z, Wang A. Group Testing in a Pandemic: The Role of Frequent, Correlated Testing, and Machine Learning. NBER Working Paper Series 27457. 2020; Cambridge MA: National Bureau of Economic Research, Accessed September 29, 2020.
Bukhari SUK, Khalid SS, Syed A, Shah SSH. Smart pooled sample testing for Covid-19: a possible solution for sparsity of test kits. medRxiv: Preprint 2020.
Cherif A, Grobe N, Wang X. Simulation of pool testing to identify patients with coronavirus disease 2019 under conditions of limited test availability. JAMA Netw Open 2020; 3:e2013075.
Eberhardt JN, Breuckmann NP, Eberhardt CS. Multi-stage group testing improves efficiency of large-scale Covid-19 screening. J Clin Virol 2020; 128:104382.
Eis-Hubinger AM, Honemann M, Wenzel JJ, et al. Ad hoc laboratory-based surveillance of SARS-CoV-2 by real-time RT-PCR using minipools of RNA prepared from routine respiratory samples. J Clin Virol 2020; 127:104381.
Escobar M, Jeanneret G, Bravo-Sanchez L, et al. Smart pooling: AI powered COVID-19 testing. medrxiv 2020; Available at: https://www.medrxiv.org/content/10.1101/2020.07.13.20152983v1.full.pdf. Accessed September 29, 2020.
Fang L, Ling S, Jing B, Yang Q. Fast: a flexible, accurate and speedy test strategy for COVID-19. medRxiv: Preprint 2020; Accessed September 29, 2020.
Farfan MJ, Torres JP, O’Ryan M, et al. Optimizing RT-PCR detection of SARS-CoV-2 for developing countries using pool testing. medRxiv: Preprint 2020.
Gan Y, Du L, Damola FO, Huang J, Xiao G, Lyu X. Sample pooling as a strategy of SARS-COV-2 nucleic acid screening increases the false-negative rate. medRxiv: Preprint 2020.
Gollier C, Gossner O. 2020. Group testing against COVID-19. LSE Research Online. Available at: http://www.lse.ac.uk/school-of-public-policy/COVID-19-resource-centre.
Griesmer SB, Van Slyke G, St. Gerorg TC. Assessment of sample pooling for clinical SARS-CoV-2 testing. biorxiv 2020.
Guha P, Guha A, Bandyopadhyay T. Application of pooled testing in screening and estimating the prevalence of Covid-19. medRxiv: Preprint 2020.
Gundersen K, Kvaloy JT, Gjessing HK, Löhr IH. Efficient prevalence estimation and population screening for SARS-CoV-2. medRxiv 2020; https://www.medrxiv.org/10.1101/2020.05.18.20105882v1
Hanel R, Thurner S. Boosting test-efficiency by pooled testing strategies for SARS-CoV-2. Biology arXiv Populations and evolution 2020; https://arxiv.org/pdf/2003.09944.pdf
Heidarzadeh A, Narayanan NK. Two-stage adaptive pooling with RT-PCR for COVID-19 screening. arXiv 2020.
Hirotsa Y, Maejims M, Shibugawn M, et al. Pooling RT-PCR test of SARS-CoV-2 for large cohort of “healthy” and infection suspected patients: a prospective and consecutive study on 1000 individuals. medRxiv preprint 2020.
Millioni R, Mortarino C. Sequential informed pooling approach to detect SARS-CoV2 infection. medRxiv: Preprint 2020.
Mutzel P, Bertram A, Jünger P, et al. Increasing virus test capacity via recursive pool testing with an application to SARS-CoV-2 testing. medRxiv 2020.
Noriega R, Samore MH. Increasing testing throughput and case detection with a pooled-sample Bayesian approach in the context of COVID-19. bioRxiv 2020; https://www.biorxiv.org/content/10.1101/2020.04.03.024216v1.full.pdfhttps://www.biorxiv.org/content/10.1101/2020.04.03.024216v1.full.pdf. Accessed September 29, 2020.
Pikovski A, Bentele K. Remarks on pooling Coronavirus tests. medrxiv 2020; https://www.medrxiv.org/content/10.1101/2020.06.08.20125781v1
Shani-Narkiss H, Gilday OD, Yayon N, Landau ID. Efficient and practical sample pooling for high-throughput PCR diagnosis of COVID-19. medRxiv: Preprint 2020.
Sharma R, Goyal S, Bist P. Optimal sample pooling: an efficient tool against SARS-CoV-2. medrxiv 2020; https://www.medrxiv.org/content/10.1101/2020.07.03.20145953v1
Shental N, Levy S, Skorniakov S, et al. Efficient high throughput SARS-CoV-2 testing to detect asymptomatic carriers. medRxiv: Preprint 2020.
Skorniakov V, Leipus R, Juzeliunas G, Staliunas K. Optimal group based testing strategy for detecting infected individuals: comparison of algorithms. medRxiv 2020; https://www.medrxiv.org/content/10.1101/2020.06.29.20142323v1
Szapudi I. Efficient sample pooling strategies for COVID-19 data gathering 2020. medRxiv: Preprint 2020; Accessed September 29, 2020.
Täufer M. Rapid, large-scale, and effective detection of COVID-19 via nonadaptive testing. biorxiv. J Theoretical Biol 2020; 506https://doi.org/10.1016/jtbi.2020.110150https://doi.org/10.1016/jtbi.2020.110150. Accessed September 29, 2020.
doi: 10.1016/jtbi.2020.110150
Verdun CM, Fuchs T, Harar P, et al. Group testing for SARS-CoV-2 allows for up to 10-fold efficiency increase across realistic scenarios and testing strategies. medRxiv 2020; https://www.medrxiv.org/content/10.1101/2020.04.30.20085290v2.full.pdf
Viehweger A, Kühnl F, Brandt C, König B. Increased PCR screening capacity using a multi-replicate pooling scheme. medRxiv: Preprint 2020.
Wacharapluesadee S, Kaewpom T, Ampoot W, et al. Evaluating the efficiency of specimen pooling for PCR-based detection of COVID-19. J Med Virol 2020; 92:2193–2199.
Žilinskas J, Lančinskas A, Guarracino MR. Pooled testing with replication: a mass testing strategy for the COVID-19 pandemics. medRxiv: Preprint 2020; doi:.
Centers for Disease Control and Prevention. Contact tracing for COVID-19; 2020c. Available at: https://www.cdc.gov/coronavirus/2019-ncov/php/contact-tracing/contact-tracing-plan/contact-tracing.html. Accessed September 29, 2020.
Centers for Disease Control and Prevention. SARS-CoV-2 Testing Strategy: Considerations for Non-Healthcare Workplaces; 2020d. Available at: https://www.cdc.gov/coronavirus/2019-ncov/community/organizations/testing-non-healthcare-workplaces.html. Accessed September 29, 2020.
Equal Opportunity Employment Commission. What you should know about COVID-19 and the ADA, The Rehabilitation Act, and Other EEO laws. Available at: https://www.eeoc.gov/wysk/what-you-should-know-about-covid-19-and-ada-rehabilitation-act-and-other-eeo-laws. Accessed September 29, 2020.
Centers for Disease Control and Prevention. Duration of Isolation Precautions for Adults with COVID-19; 2020e. Available at: https://www.cdc.gov/coronavirus/2019-ncov/hcp/duration-isolation.html. Accessed September 29, 2020.
Gupta E, Padhi A, Khodare A, et al. Pooled RNA sample reverse transcriptase real time PCR assay for SARS-CoV-2 infection a reliable, faster and economic method. PLOS ONE 2020; https://doi.org/10.1371/journal.pone0236859https://doi.org/10.1371/journal.pone0236859. Accessed September 29, 2020.
doi: 10.1371/journal.pone0236859
Centers for Disease Control and Prevention. Interim Laboratory Biosafety Guidelines for Handling and Processing Specimens Associated with Coronavirus Disease 2019 (COVID-19); 2020f. Available at: https://www.cdc.gov/coronavirus/2019-cov/ab/ab-biosafety_guidelines.html. Accessed September 29, 2020.
Centers for Disease Control and Prevention. Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens for COVID-19. Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 (COVID-19); 2020g. Available at: https://www.cdc.gpv/nCoV/lab/guidelines-clinical-specimens.html. Accessed September 29, 2020.
European Center for Disease Prevention and Control 2020. Available at: https://www.ecdc.europa.eu/sites/default/files/documents/Methodology-estimating-point-prevalence%20-SARS-CoV-2-infection-pooled-RT-PCR-testing.pdf. Accessed September 29, 2020.
Food and Drug Administration. Coronavirus (COVID-19) Update: Facilitating diagnostic test availability for asymptomatic testing and sample pooling. Available at: https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-facilitating-diagnostic-test-availability-asymptomatic-testing-and.
Ejima K, Kim KS, Ito Y, et al. Inferring timing of infection using within-host sars-CoV-2 infection dynamics model: are ‘imported cases’ truly imported? medRxiv 2020.
Zou L, Ruan F, Huang M, et al. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. N Engl J Med 2020; 382:1177–1179.
Pouwels KB, Roope LSJ, Barnett A, Hunler DJ, Nolan TM, Clarke PM. Group testing for SARS-CoV-2: Forward to the past? Pharmacoecono Open 2020; 4:207–201.
CMS (Centers for Medicare and Medicaid). Regulatory guidance pertaining to sample pooling. Available at: https://www.cms.gov/files/document/06-19-2020-frequently-asked-questions-covid-surveillance-testing.pdf.
Yang Y, Yang M, Shen C, Wang F, et al. Evaluating the accuracy of different respiratory specimens in the laboratory diagnosis and mentoring of viral shedding of 2019-nCoV infections. medRxiv 2020; https://www.medrxiv.org/content/10.1101/2020.02.11.20021493v2.full.pdf
Lakdawalla D, Trish E. Group testing for coronavirus—called pooled testing—could be the fastest and cheapest way to increase screening nationwide The Conversation; 2020; Available at: https://theconversation.com/group-testing-for-coronavirus-called-pooled-testing-could-be-the-fastest-and-cheapest-way-to-increase-screening-nationwaide-141579. Accessed September 29, 2020.
Aprahamian H, Bish DR, Bish EK. Optimal risk-based group testing. Manage Sci 2019; 65:4365–4384.
Black M, Bilder CR, Tebbs J. Group testing in heterogenous populations by using halving algorithms. J Royal Stat Soc, Series C 2012; 61:277–290.
Larremore DB, Wilder B, Lester E, Shehata S, Burke JM, Hay J et al. Test sensitivity is secondary to frequency and turnaround time for COVID-19 surveillance. Available at: https://www.medrxiv.org/content/10.1101/2020.06.22.20136309v2.full.pdf.
State of California Testing Task Force. 2020 June 24. Available at: https://testing.covid19.ca.gov/wp-content/uploads/sites/332/2020/06/COVID-pooling_FINAL-6-24-2020_edited-for-ADA-compliance.pdf. Accessed September 29, 2020.
Kiyuka PK, Agoti CW, Munywok PK, et al. Human coronavirus NL63 molecular epidemiology and evolutionary patterns in rural costal Kenya. J Inf Dis 2018; 217:1728–1739. 5.
Esbin MN, Whitney ON, Chong S, Maurer A, Darzacq X, Tjian R. Overcoming the bottleneck to widespread testing: A rapid review of nucleic acid testing approaches for COVID-19 detection. RNA 2020; 26:771–783.
Mallapaty S. The mathematical strategy that could transform coronavirus testing. Nature 2020; 583:504–505.
Vogels CBF, Watkins AE, Brackney DE, et al. Saliva-Direct: Simple and sensitive molecular diagnostic test for SARS-CoV-2 surveillance. medRxiv: Preprint 2020.
Wyllie AL, Fournies J, Cassanovas-Massang A, et al. Saliva is more sensitive for SARS-CoV-2 detection in COVID-19 patients than nasopharyngeal swabs. Medrxiv Available at: https://doi.org/10.1101/2020.04.16.20067835. Accessed September 29, 2020.
doi: 10.1101/2020.04.16.20067835